Basic Essentials Astringent

Description

Basic Essentials Astringent is a topical formulation designed to reduce excess oil and tighten the skin. It is characterized by its astringent properties, which help to minimize the appearance of pores and improve skin texture. The product is intended for use in managing oily skin conditions and may assist in the prevention of acne.

Uses and Indications

This drug is indicated for the treatment of acne. There are no teratogenic or nonteratogenic effects associated with its use as mentioned in the available data.

Dosage and Administration

Patients should begin by washing their face as they normally would and patting it dry with a clean towel. A small amount of the astringent should then be applied to a cotton ball or pad. The astringent should be applied using a dabbing motion, taking care to avoid contact with the eyes.

The recommended frequency of application is two to three times daily, or as directed by a healthcare professional, to maintain clear and healthy skin. Following the application of the astringent, it is advisable to apply a light moisturizer to help mitigate any potential dryness.

In the event that bothersome drying or peeling occurs, patients should reduce the frequency of application as necessary.

Contraindications

Use is contraindicated in children due to the risk of accidental ingestion. In the event of ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

Warnings and Precautions

For external use only. This product is flammable; it should be kept away from open flames to prevent fire hazards.

In the event of accidental ingestion, it is imperative to seek emergency medical assistance or contact a Poison Control Center immediately.

Patients are advised to discontinue use and consult their healthcare provider if they are concurrently using other topical acne medications. The simultaneous application of such products may exacerbate skin dryness or irritation. In such cases, only one topical medication should be utilized unless otherwise directed by a healthcare professional.

Side Effects

Patients should be aware that this product is for external use only and is flammable; it should be kept away from open flames to prevent fire hazards.

In clinical practice, the concurrent use of other topical acne medications may lead to increased dryness or irritation of the skin. If patients experience such reactions, it is advised that only one medication be used at a time unless otherwise directed by a healthcare professional. This precaution is important to minimize adverse effects and ensure the safety and efficacy of treatment.

Drug Interactions

Concurrent use of other topical acne medications with this product may lead to increased dryness or irritation of the skin. In such cases, it is advisable to limit the use to one medication at a time unless otherwise directed by a healthcare professional. Monitoring for signs of excessive skin irritation is recommended to ensure patient safety and comfort.

Packaging & NDC

Below are the non-prescription pack sizes of Basic Essentials Astringent (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is recommended.

For the management of skin conditions, the astringent may be applied two to three times daily, or as directed by a healthcare professional, to maintain clear and healthy skin.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients should be aware that the safety of this medication during pregnancy has not been specifically established. There are no available data regarding potential risks or fetal outcomes associated with its use in pregnant individuals. Healthcare professionals are advised to consider the lack of information when prescribing this medication to women of childbearing potential and to weigh the potential benefits against any unknown risks. It is recommended that healthcare providers discuss the implications of medication use during pregnancy with their patients, ensuring informed decision-making.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available concerning the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or toxicology experts for guidance on specific management strategies tailored to the substance involved.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective treatment and follow-up care.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event that the product is swallowed, patients should be instructed to seek medical help or contact a Poison Control Center immediately.

Additionally, it is important for healthcare providers to discuss the potential for increased dryness or irritation of the skin when using this product in conjunction with other topical acne medications. Patients should be informed that if they experience such symptoms, they should use only one medication at a time unless otherwise directed by a healthcare professional.

Storage and Handling

The product is classified as flammable and must be kept away from open flames to ensure safety during storage and handling. It is essential to keep the product out of reach of children to prevent accidental ingestion. In the event of accidental swallowing, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

Proper storage conditions should be observed to maintain product integrity and safety.

Additional Clinical Information

The product is administered topically, with a recommended frequency of two to three times daily or as directed by a healthcare professional to maintain clear and healthy skin. Clinicians should advise patients to avoid contact with the eyes; in the event of contact, patients should flush the area thoroughly with water.

Patients should be cautioned against the concurrent use of other topical acne medications, as this may exacerbate skin dryness or irritation. If significant drying or peeling occurs, patients are advised to reduce the frequency of application.

Drug Information (PDF)

This file contains official product information for Basic Essentials Astringent, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)